Acute Lymphoblastic Leukemia, With KMT2A Rearrangements
1 clinical trials · Condition
◉ Watch Acute Lymphoblastic Leukemia, With KMT2A Rearrangements
| Record | Firm | Date |
|---|---|---|
| Expanded Access to Ziftomenib (NCT05738538) | Kura Oncology, Inc. |
Track Acute Lymphoblastic Leukemia, With KMT2A Rearrangements automatically
Every clearance here is in the API, with alerts when new ones post.